These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25274580)

  • 21. Is the breast cancer mortality decrease in Sweden due to screening or treatment? Not the right question.
    Segnan N; Rosso S; Ponti A
    J Natl Cancer Inst; 2012 Jul; 104(14):1040-1. PubMed ID: 22811441
    [No Abstract]   [Full Text] [Related]  

  • 22. Age to Begin and Intervals for Breast Cancer Screening: Balancing Benefits and Harms.
    Destounis S; Santacroce A
    AJR Am J Roentgenol; 2018 Feb; 210(2):279-284. PubMed ID: 29064754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?
    Rahbar H; McDonald ES; Lee JM; Partridge SC; Lee CI
    Acad Radiol; 2016 Jun; 23(6):768-73. PubMed ID: 27017136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.
    Berg WA; Bandos AI; Mendelson EB; Lehrer D; Jong RA; Pisano ED
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluating the benefits of mammographic breast cancer screening].
    Kullmann T; Misset JL
    Orv Hetil; 2010 Aug; 151(35):1409-14. PubMed ID: 20719714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technologists' Characteristics and Quality of Positioning in Daily Practice in a Canadian Breast Cancer Screening Program.
    Guertin MH; Théberge I; Zomahoun HT; Dufresne MP; Pelletier É; Brisson J
    Acad Radiol; 2016 Nov; 23(11):1359-1366. PubMed ID: 27567127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients.
    Le-Petross HT; Shetty MK
    Semin Ultrasound CT MR; 2011 Aug; 32(4):266-72. PubMed ID: 21782116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACP Journal Club. Annual mammography screening did not reduce long-term breast cancer mortality in women 40 to 59 years of age.
    Fletcher SW
    Ann Intern Med; 2014 May; 160(10):JC7. PubMed ID: 24842441
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of a mammography screening program within the population-based Vorarlberg Health Monitoring & Prevention Program (VHM&PP).
    Nagel G; Oberaigner W; Peter RS; Ulmer H; Concin H
    Cancer Epidemiol; 2015 Dec; 39(6):812-8. PubMed ID: 26651439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Developments in Breast Cancer Screening and Treatment.
    Dinardo D; McNeil M
    J Womens Health (Larchmt); 2019 Apr; 28(4):423-426. PubMed ID: 30969906
    [No Abstract]   [Full Text] [Related]  

  • 32. Breast cancers detected in only one of two arms of a tomosynthesis (3D-mammography) population screening trial (STORM-2).
    Bernardi D; Houssami N
    Breast; 2017 Apr; 32():98-101. PubMed ID: 28107735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening mammography--early detection or over-diagnosis? Contribution from Australian data.
    Bell RJ
    Climacteric; 2014 Dec; 17 Suppl 2():66-72. PubMed ID: 25224048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
    Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
    Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up.
    Sankatsing VDV; van Ravesteyn NT; Heijnsdijk EAM; Looman CWN; van Luijt PA; Fracheboud J; den Heeten GJ; Broeders MJM; de Koning HJ
    Int J Cancer; 2017 Aug; 141(4):671-677. PubMed ID: 28457023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mortality in breast cancer is decreasing--but not because of screening. Time to abolish the mammography screening].
    Jørgensen KJ; Gøtzsche PC
    Lakartidningen; 2012 Mar 28-Apr 3; 109(13):690-2. PubMed ID: 22530466
    [No Abstract]   [Full Text] [Related]  

  • 37. More on screening mammography.
    Fletcher SW; Elmore JG
    N Engl J Med; 2011 Jan; 364(3):283; author reply 285-6. PubMed ID: 21247321
    [No Abstract]   [Full Text] [Related]  

  • 38. Breast cancer screening: science, society and common sense.
    Lyman GH
    Cancer Invest; 2010 Jan; 28(1):1-6. PubMed ID: 20001293
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: "Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial".
    Weiss NS
    Am J Epidemiol; 2014 Oct; 180(7):759-60. PubMed ID: 25194149
    [No Abstract]   [Full Text] [Related]  

  • 40. Flawed methods explain the effect of mammography screening in Nijmegen.
    Jørgensen KJ
    Br J Cancer; 2011 Aug; 105(4):592-3; author reply 594-5. PubMed ID: 21792194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.